TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Janssons Immunbiologiska AB JIBA
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
561
|
555
|
640 |
| Financial expenses |
0
|
1
|
1 |
| Earnings before taxes |
108
|
108
|
201 |
| EBITDA |
108
|
108
|
202 |
| Total assets |
296
|
296
|
252 |
| Current assets |
296
|
296
|
252 |
| Current liabilities |
50
|
54
|
81 |
| Equity capital |
245
|
242
|
171 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
5 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
82.8%
|
81.8%
|
67.9% |
| Turnover per employee |
280
|
278
|
128 |
| Profit as a percentage of turnover |
19.3%
|
19.5%
|
31.4% |
| Return on assets (ROA) |
36.5%
|
36.8%
|
80.2% |
| Current ratio |
592.0%
|
548.1%
|
311.1% |
| Return on equity (ROE) |
44.1%
|
44.6%
|
117.5% |
| Change turnover |
5
|
-33
|
-55 |
| Change turnover % |
1%
|
-6%
|
-8% |
| Chg. No. of employees |
0
|
-3
|
0 |
| Chg. No. of employees % |
0%
|
-60%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.